KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) EBT (2017 - 2025)

Arcosa (ACA) has disclosed EBT for 9 consecutive years, with $55.2 million as the latest value for Q4 2025.

  • Quarterly EBT rose 430.77% to $55.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.3 million through Dec 2025, up 85.62% year-over-year, with the annual reading at $241.3 million for FY2025, 85.62% up from the prior year.
  • EBT hit $55.2 million in Q4 2025 for Arcosa, down from $87.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $199.9 million in Q4 2022 to a low of $8.2 million in Q4 2021.
  • Historically, EBT has averaged $48.3 million across 5 years, with a median of $41.8 million in 2022.
  • Biggest five-year swings in EBT: surged 2337.8% in 2022 and later plummeted 81.74% in 2023.
  • Year by year, EBT stood at $8.2 million in 2021, then soared by 2337.8% to $199.9 million in 2022, then tumbled by 81.74% to $36.5 million in 2023, then plummeted by 71.51% to $10.4 million in 2024, then soared by 430.77% to $55.2 million in 2025.
  • Business Quant data shows EBT for ACA at $55.2 million in Q4 2025, $87.1 million in Q3 2025, and $69.8 million in Q2 2025.